VERACYTE, INC. Annual Deferred Income Tax Expense (Benefit) in USD from 2019 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Veracyte, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2019 to 2024.
- Veracyte, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
- Veracyte, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was -$230K, a 94.1% increase from 2023.
- Veracyte, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$3.92M, a 818% decline from 2022.
- Veracyte, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$427K, a 93.1% increase from 2021.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)